

HoxD9 Antibody (B-1) is a mouse monoclonal IgG3 antibody that detects HoxD9 in mouse, rat, and human samples through applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), and enzyme-linked immunosorbent assay (ELISA). HoxD9 is a critical transcription factor involved in the regulation of embryonic development and cellular differentiation, primarily by modulating downstream target genes. HoxD9 plays a significant role in the early stages of mouse joint development, showing predominant expression in articular cartilage, which is essential for joint function and integrity. HoxD9 transcripts have been found in the synovial tissue of arthritic mice, indicating a potential involvement in the pathology of arthritis. HoxD9 is highly expressed in the synoviocytes of patients with rheumatoid arthritis, while showing no expression in those with osteoarthritis, suggesting a specific role in rheumatoid arthritis pathology. The differential expression of HoxD9 in the human cervical cancer cell line HeLa, compared to normal cervical tissue, points to potential involvement in tumorigenesis. Anti-HoxD9 antibody (B-1) serves as an invaluable tool for researchers investigating HoxD9′s complex roles in development and disease, providing insights into regulatory mechanisms and interactions within various biological contexts.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HoxD9 Antibody (B-1) | sc-374486 | 200 µg/ml | $322.00 | |||
HoxD9 Antibody (B-1): m-IgG3 BP-HRP Bundle | sc-550450 | 200 µg Ab; 40 µg BP | $361.00 | |||
HoxD9 (B-1) Neutralizing Peptide | sc-374486 P | 100 µg/0.5 ml | $69.00 | |||
HoxD9 Antibody (B-1) X | sc-374486 X | 200 µg/0.1 ml | $322.00 |